Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Top Stocks to Buy: Amazon Stock vs. Alibaba Stock: https://g.foolcdn.com/editorial/images/747223/untitled-design-58.png
Top Stocks to Buy: Amazon Stock vs. Alibaba Stock

Fool.com contributor Parkev Tatevosian pits Amazon (NASDAQ: AMZN) against Alibaba (NYSE: BABA) to find out which is the better stock to buy.

*Stock prices used were the afternoon prices of Sept. 8

Palantir Stock: Buy, Sell, or Hold?: https://g.foolcdn.com/editorial/images/747222/palantir-buy-sell-hold.png
Palantir Stock: Buy, Sell, or Hold?

Fool.com contributor Parkev Tatevosian evaluates Palantir (NYSE: PLTR) stock to answer if it's an excellent buy at current valuations.

*Stock prices used were the afternoon prices of Sept. 8, 2023

E3 Lithium Provides Overview of Saskatchewan Lithium Assets: https://mms.businesswire.com/media/20230912308244/en/1886765/5/SK_Map.jpg
E3 Lithium Provides Overview of Saskatchewan Lithium Assets


E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), “E3 Lithium” or “the Company,” Alberta’s leading lithium developer and extraction technology innovator, today provides an overview of its

Teledyne FLIR Defense Demonstrates Groundbreaking UAV Vehicle Reconnaissance Technology at DSEI in London: https://mms.businesswire.com/media/20230911604523/en/1885337/5/BLACK_RECON-Standalone_Configuration.jpg
Teledyne FLIR Defense Demonstrates Groundbreaking UAV Vehicle Reconnaissance Technology at DSEI in London


Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), is showcasing a new technology concept at this week’s DSEI conference in London that will allow crews to autonomously

EQS-News: PNE AG continues to be successful in onshore wind power tenders: https://upload.wikimedia.org/wikipedia/de/thumb/0/0d/PNE_Logo.png/640px-PNE_Logo.png
EQS-News: PNE AG continues to be successful in onshore wind power tenders
EQS-News: PNE AG continues to be successful in onshore wind power tenders
EQS-News: ADLER Real Estate AG: Special audit requested by SdK rejected by the court: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24087/Adler_Real_Estate_logo.svg.png
EQS-News: ADLER Real Estate AG: Special audit requested by SdK rejected by the court
EQS-News: ADLER Real Estate AG: Special audit requested by SdK rejected by the court
MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies: https://mms.businesswire.com/media/20230911939710/en/1882715/5/Facility.jpg
MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies


MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for

EQS-News: Vossloh Aktiengesellschaft: Deutsche Bahn and Vossloh expand their cooperation in preventive rail maintenance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24129/375px-Vossloh_Logo.svg.png
EQS-News: Vossloh Aktiengesellschaft: Deutsche Bahn and Vossloh expand their cooperation in preventive rail maintenance
EQS-News: Vossloh Aktiengesellschaft: Deutsche Bahn and Vossloh expand their cooperation in preventive rail maintenance
EQS-News: Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
EQS-News: Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
EQS-News: Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
Nordea Bank Abp: Transaction in Own Shares: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24153/330px-Nordea_logo.svg.png
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Oracle (ORCL) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Oracle (ORCL) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Oracle (NYSE: ORCL)Q1 2024 Earnings CallSep 11, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Can US Solar Avoid the Same Financing Doldrums as Wind Power?: https://g.foolcdn.com/editorial/images/747345/featured-daily-upside-image.png
Can US Solar Avoid the Same Financing Doldrums as Wind Power?

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

The sun and the

Disney/Charter Huddle Avoids a Dreaded MNF Blackout: https://g.foolcdn.com/editorial/images/747344/featured-daily-upside-image.png
Disney/Charter Huddle Avoids a Dreaded MNF Blackout

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Now that's

Smuckers Building Snack-Food Empire With Hostess Deal: https://g.foolcdn.com/editorial/images/747343/featured-daily-upside-image.jpeg
Smuckers Building Snack-Food Empire With Hostess Deal

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Smuckers has a

Why Marijuana Stocks Triumphed on Monday: https://g.foolcdn.com/editorial/images/747334/person-in-lab-gear-inspecting-a-marijuana-plant-inside-a-grow-facility.jpg
Why Marijuana Stocks Triumphed on Monday

Cannabis stocks have become quite the hot item on the stock exchange lately, a trend that stretched into Monday's trading. A clutch of "green" companies saw their share prices improve on the first

Why CymaBay Therapeutics Stock Popped Again Today: https://g.foolcdn.com/editorial/images/747329/person-in-a-lab-looking-through-a-microscope.jpg
Why CymaBay Therapeutics Stock Popped Again Today

For the third day in a row, shares of CymaBay Therapeutics (NASDAQ: CBAY) enjoyed a very healthy gain in price. That came on the announcement of a capital-raising effort by the company. Ultimately

Why Alibaba Stock Got Mashed on Monday: https://g.foolcdn.com/editorial/images/747326/concerned-person-concentrating-on-a-laptop-display.jpg
Why Alibaba Stock Got Mashed on Monday

An unexpected change in top leadership at a major business unit was the reason for Alibaba (NYSE: BABA) stock's slide on Monday. The Chinese tech giant's shares lost 1.5% of their value on the news

Desktop Metal Announces Sale of Production System P-50 and Super Fleet of Metal Binder Jet Systems to FreeFORM Technologies: https://mms.businesswire.com/media/20230911784813/en/1886774/5/FreeFORM_President_Nate_Higgins_with_Desktop_Metal_X25Pro.jpg
Desktop Metal Announces Sale of Production System P-50 and Super Fleet of Metal Binder Jet Systems to FreeFORM Technologies


Desktop Metal, Inc. (NYSE: DM), a global leader in additive manufacturing technologies for mass production, today announced the sale of a Production System P-50 and a full fleet of metal binder jet

Why Shares of EyePoint Pharmaceuticals Were Rising Monday: https://g.foolcdn.com/editorial/images/747294/optometrist-covering-her-patients-eyes-with-an-occluder-during-an-eye-exam.jpg
Why Shares of EyePoint Pharmaceuticals Were Rising Monday

Shares of EyePoint Pharmaceuticals (NASDAQ: EYPT) were up more than 20% as of 2:30 p.m. ET on Monday after the healthcare company announced interim masked trial data for its lead therapy to treat

Why fuboTV Stock Popped and Then Dropped Today: https://g.foolcdn.com/editorial/images/747292/streaming-tv.jpg
Why fuboTV Stock Popped and Then Dropped Today

Shares of fuboTV (NYSE: FUBO) were taking a dive after initially popping early this morning as the sports-based streaming service responded poorly to news that Disney (NYSE: DIS) and Charter

Why Canopy Growth, Aurora Cannabis, and Tilray Stocks All Exploded Higher Today: https://g.foolcdn.com/editorial/images/747291/rising-stock-chart-is-labeled-cannabis-inc-with-dollar-signs-and-marijuana-leaves-decorating.jpg
Why Canopy Growth, Aurora Cannabis, and Tilray Stocks All Exploded Higher Today

Marijuana stocks lit up the stock market again on Monday, with shares of Tilray Brands (NASDAQ: TLRY), for example, gaining 9.4% through 1:25 p.m. ET. Gains at two of the three other best-known

Why Shares of Bicycle Therapeutics Were Rising on Monday: https://g.foolcdn.com/editorial/images/747289/research-scientists-drugs-pharma-biotech.jpg
Why Shares of Bicycle Therapeutics Were Rising on Monday

Shares of Bicycle Therapeutics (NASDAQ: BCYC) were up 9% as of 1:30 p.m. ET on Monday after the healthcare stock climbed as high as 10.4% earlier in the day. The company's shares are still down more

Why Fisker Stock Jumped Today: https://g.foolcdn.com/editorial/images/747262/fisker-ocean-charging.png
Why Fisker Stock Jumped Today

Shares of electric vehicle (EV) start-up Fisker (NYSE: FSR) jumped as much as 5% Monday morning as investors digested new updates from the company. As of 1:20 p.m. ET today, the shares were holding

Why Shares of Crinetics Pharmaceuticals Are Jumping Monday: https://g.foolcdn.com/editorial/images/747255/pharmacy-pharmacist-drug-medicine-prescription-2.jpg
Why Shares of Crinetics Pharmaceuticals Are Jumping Monday

Shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) were up more than 67% as of 12:30 p.m. ET on Monday after the company posted positive phase 3 trial results for one of its therapies. The healthcar

2 Deep Value Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/746922/stock-trader-2022-a.jpg
2 Deep Value Stocks to Buy Right Now

While it's true that stock market bargains are a little tougher to find than they were at the start of 2023, there are still plenty of them out there. In this video, Fool.com contributor Tyler Crowe